Tapewire

Nasdaq · USD

OCUL

OCULAR THERAPEUTIX, INC

Export transactions ↓
Tapewire entity
273
SEC CIK
0001393434
Parsed reports
288

Last 12 months

Inside the activity.

1 purchase rows · 29 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202500
Jan 202600
Feb 2026111
Mar 202600
Apr 202600
May 202604
Jun 202601
Jul 202600
Aug 202605
Sep 202600
Oct 202603

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 25, 2020 Filed Jun 26, 2020 16:04 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $8.75 $0.00
Disclosure

SEC source: 0001104659-20-077449 · a4.xml · derivative · entry 1

LINDSTROM RICHARD L MD · CIK 0001242177 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2030-06-24

F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date.

Read SEC document
June 25, 2020 Filed Jun 26, 2020 16:02 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $8.75 $0.00
Disclosure

SEC source: 0001104659-20-077440 · a4.xml · derivative · entry 1

PEACOCK BRUCE · CIK 0001228459 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2030-06-24

F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date.

Read SEC document
June 25, 2020 Filed Jun 26, 2020 20:03 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $8.75 $0.00
Disclosure

SEC source: 0001104659-20-077446 · a4.xml · derivative · entry 1

Williams Leslie J. · CIK 0001770465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2030-06-24

F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date.

Read SEC document
June 25, 2020 Filed Jun 26, 2020 20:04 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $8.75 $0.00
Disclosure

SEC source: 0001104659-20-077448 · a4.xml · derivative · entry 1

Hong Seung Suh · CIK 0001774271 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2030-06-24

F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date.

Read SEC document
June 25, 2020 Filed Jun 26, 2020 20:03 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $8.75 $0.00
Disclosure

SEC source: 0001104659-20-077441 · a4.xml · derivative · entry 1

Heier Jeffrey S. · CIK 0001653082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2030-06-24

F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date.

Read SEC document
May 19, 2020 Filed May 21, 2020 20:15 UTC PurchaseCommon Stock, $0.0001 par value per share 363,636 $5.50 $1,999,998.00
Disclosure

SEC source: 0001567619-20-010898 · doc1.xml · nonDerivative · entry 1

SUMMER ROAD LLC · CIK 0001604873 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Client

Disclosed balance after: 5,618,424

F1 · shares: These shares of Common Stock, $0.0001 par value per share (the "Shares"), were purchased directly from the underwriters in an underwritten public offering conducted by the Issuer on May 19, 2020 (the "Offering"). Pursuant to the Offering, the Reporting Person agreed to purchase the Shares at a public offering price of $5.50 per share. The Issuer's Rule 424(b)(5) prospectus supplement (File No. 333-229085) in connection with the Offering was filed with the Securities and Exchange Commission (the "SEC") on May 20, 2020.

F1 · price: These shares of Common Stock, $0.0001 par value per share (the "Shares"), were purchased directly from the underwriters in an underwritten public offering conducted by the Issuer on May 19, 2020 (the "Offering"). Pursuant to the Offering, the Reporting Person agreed to purchase the Shares at a public offering price of $5.50 per share. The Issuer's Rule 424(b)(5) prospectus supplement (File No. 333-229085) in connection with the Offering was filed with the Securities and Exchange Commission (the "SEC") on May 20, 2020.

F2 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the SEC on March 4, 2019, as amended from time to time.

F3 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F2 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the SEC on March 4, 2019, as amended from time to time.

F3 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F2 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the SEC on March 4, 2019, as amended from time to time.

F3 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

Read SEC document
March 24, 2020 Filed Mar 25, 2020 01:42 UTC PurchaseCommon Stock, $0.0001 par value per share 35,052 $4.87 $170,713.76
Disclosure

SEC source: 0001567619-20-006975 · doc1.xml · nonDerivative · entry 3

SUMMER ROAD LLC · CIK 0001604873 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Client

Disclosed balance after: 5,254,788

F5 · price: Represents the weighted average set forth in this line item. On March 24, 2020, the Reporting Person acquired 35,052 shares of Common Stock at a weighted average price of $4.8703 (ranging from a low of $4.59 and a high of $5.18). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.

F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

Read SEC document
March 23, 2020 Filed Mar 25, 2020 01:42 UTC PurchaseCommon Stock, $0.0001 par value per share 64,948 $4.66 $302,365.41
Disclosure

SEC source: 0001567619-20-006975 · doc1.xml · nonDerivative · entry 2

SUMMER ROAD LLC · CIK 0001604873 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Client

Disclosed balance after: 5,219,736

F4 · price: Represents the weighted average set forth in this line item. On March 23, 2020, the Reporting Person acquired 64,948 shares of Common Stock at a weighted average price of $4.6555 (ranging from a low of $4.09 and a high of $4.94). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.

F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

Read SEC document
March 20, 2020 Filed Mar 25, 2020 01:42 UTC PurchaseCommon Stock, $0.0001 par value per share 9,100 $4.52 $41,119.26
Disclosure

SEC source: 0001567619-20-006975 · doc1.xml · nonDerivative · entry 1

SUMMER ROAD LLC · CIK 0001604873 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Client

Disclosed balance after: 5,154,788

F3 · price: Represents the weighted average set forth in this line item. On March 20, 2020, the Reporting Person acquired 9,100 shares of Common Stock at a weighted average price of $4.5186 (ranging from a low of $4.15 and a high of $5.13). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.

F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

Read SEC document
March 19, 2020 Filed Mar 21, 2020 01:34 UTC PurchaseCommon Stock, $0.0001 par value per share 40,900 $4.63 $189,223.85
Disclosure

SEC source: 0001567619-20-006870 · doc1.xml · nonDerivative · entry 2

SUMMER ROAD LLC · CIK 0001604873 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Client

Disclosed balance after: 5,145,688

F4 · price: Represents the weighted average set forth in this line item. On March 19, 2020, the Reporting Person acquired 40,900 shares of Common Stock at a weighted average price of $4.6265 (ranging from a low of $4.40 and a high of $4.81). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.

F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

Read SEC document
March 18, 2020 Filed Mar 21, 2020 01:34 UTC PurchaseCommon Stock, $0.0001 par value per share 344,938 $4.62 $1,594,199.95
Disclosure

SEC source: 0001567619-20-006870 · doc1.xml · nonDerivative · entry 1

SUMMER ROAD LLC · CIK 0001604873 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Client

Disclosed balance after: 5,104,788

F3 · price: Represents the weighted average set forth in this line item. On March 18, 2020, the Reporting Person acquired 344,938 shares of Common Stock at a weighted average price of $4.6217 (ranging from a low of $4.14 and a high of $5.24). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.

F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

Read SEC document
March 17, 2020 Filed Mar 18, 2020 01:35 UTC PurchaseCommon Stock, $0.0001 par value per share 550,000 $4.66 $2,562,890.00
Disclosure

SEC source: 0001567619-20-006639 · doc1.xml · nonDerivative · entry 3

SUMMER ROAD LLC · CIK 0001604873 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Client

Disclosed balance after: 4,759,850

F3 · price: Represents the weighted averages set forth in this line item. On March 13, 2020, the Reporting Person acquired 210,800 shares of Common Stock at a weighted average price of $4.6299. On March 16, 2020, the Reporting Person acquired 194,262 shares of Common Stock at a weighted average price of $4.1553. On March 17, 2020, the Reporting Person acquired 550,000 shares of Common Stock at a weighted average price of $4.6598. Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price, and the range of prices for the transactions reported on this Form 4.

F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

Read SEC document
March 16, 2020 Filed Mar 18, 2020 01:35 UTC PurchaseCommon Stock, $0.0001 par value per share 194,262 $4.16 $807,216.89
Disclosure

SEC source: 0001567619-20-006639 · doc1.xml · nonDerivative · entry 2

SUMMER ROAD LLC · CIK 0001604873 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Client

Disclosed balance after: 4,209,850

F3 · price: Represents the weighted averages set forth in this line item. On March 13, 2020, the Reporting Person acquired 210,800 shares of Common Stock at a weighted average price of $4.6299. On March 16, 2020, the Reporting Person acquired 194,262 shares of Common Stock at a weighted average price of $4.1553. On March 17, 2020, the Reporting Person acquired 550,000 shares of Common Stock at a weighted average price of $4.6598. Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price, and the range of prices for the transactions reported on this Form 4.

F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

Read SEC document
March 13, 2020 Filed Mar 18, 2020 01:35 UTC PurchaseCommon Stock, $0.0001 par value per share 210,800 $4.63 $975,982.92
Disclosure

SEC source: 0001567619-20-006639 · doc1.xml · nonDerivative · entry 1

SUMMER ROAD LLC · CIK 0001604873 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Client

Disclosed balance after: 4,015,588

F3 · price: Represents the weighted averages set forth in this line item. On March 13, 2020, the Reporting Person acquired 210,800 shares of Common Stock at a weighted average price of $4.6299. On March 16, 2020, the Reporting Person acquired 194,262 shares of Common Stock at a weighted average price of $4.1553. On March 17, 2020, the Reporting Person acquired 550,000 shares of Common Stock at a weighted average price of $4.6598. Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price, and the range of prices for the transactions reported on this Form 4.

F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended.

F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person.

Read SEC document
January 30, 2020 Filed Feb 3, 2020 23:28 UTC
Mattessich Antony C.Director · President and CEO
GrantStock Option (Right to Buy) · Derivative 360,000 $0.00 Strike: $4.39 $0.00
Disclosure

SEC source: 0001104659-20-009945 · a4.xml · derivative · entry 1

Mattessich Antony C. · CIK 0001709900 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 360,000

Underlying: Common Stock · 360,000 shares

Expires 2030-01-29

F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Read SEC document
January 30, 2020 Filed Feb 3, 2020 18:27 UTC
Goldstein Michael H.Chief Medical Officer
GrantStock Option (Right to Buy) · Derivative 215,000 $0.00 Strike: $4.39 $0.00
Disclosure

SEC source: 0001104659-20-009939 · a4.xml · derivative · entry 1

Goldstein Michael H. · CIK 0001691259 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,000

Underlying: Common Stock · 215,000 shares

Expires 2020-01-29

F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Read SEC document
January 30, 2020 Filed Feb 3, 2020 23:28 UTC
Kitchen PatriciaChief Operations Officer
GrantStock Option (Right to Buy) · Derivative 215,000 $0.00 Strike: $4.39 $0.00
Disclosure

SEC source: 0001104659-20-009943 · a4.xml · derivative · entry 1

Kitchen Patricia · CIK 0001781346 · Chief Operations Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,000

Underlying: Common Stock · 215,000 shares

Expires 2030-01-29

F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Read SEC document
January 30, 2020 Filed Feb 3, 2020 23:27 UTC
Notman DonaldChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 215,000 $0.00 Strike: $4.39 $0.00
Disclosure

SEC source: 0001104659-20-009941 · a4.xml · derivative · entry 1

Notman Donald · CIK 0001718019 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,000

Underlying: Common Stock · 215,000 shares

Expires 2030-01-29

F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Read SEC document
January 02, 2020 Filed Jan 4, 2020 00:45 UTC PurchaseCommon Stock, par value $0.0001 per share 15,000 $3.90 $58,507.50
Disclosure

SEC source: 0001493152-20-000167 · ownership.xml · nonDerivative · entry 1

Opaleye Management Inc. · CIK 0001595855 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Opaleye, L.P.

Disclosed balance after: 4,918,500

F1 · price: The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $3.9005. The range of purchase prices on the transaction date was $3.895 to $3.94 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

F2 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.

Read SEC document
December 30, 2019 Filed Jan 2, 2020 22:15 UTC PurchaseCommon Stock, par value $0.0001 per share 5,000 $3.97 $19,852.50
Disclosure

SEC source: 0001493152-20-000059 · ownership.xml · nonDerivative · entry 2

Opaleye Management Inc. · CIK 0001595855 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Managed Account

Disclosed balance after: 207,500

F1 · price: The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $3.9705. The range of purchase prices on the transaction date was $3.93 to $3.98 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

F3 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.

Read SEC document
December 30, 2019 Filed Jan 2, 2020 22:15 UTC PurchaseCommon Stock, par value $0.0001 per share 15,000 $3.97 $59,557.50
Disclosure

SEC source: 0001493152-20-000059 · ownership.xml · nonDerivative · entry 1

Opaleye Management Inc. · CIK 0001595855 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Opaleye, L.P.

Disclosed balance after: 4,903,500

F1 · price: The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $3.9705. The range of purchase prices on the transaction date was $3.93 to $3.98 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

F2 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. ("Opaleye") may be deemed to beneficially own the securities owned directly by the Fund.

Read SEC document
July 01, 2019 Filed Jul 3, 2019 20:28 UTC
Kitchen PatriciaChief Operations Officer
GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $4.62 $0.00
Disclosure

SEC source: 0001104659-19-039308 · a4.xml · derivative · entry 1

Kitchen Patricia · CIK 0001781346 · Chief Operations Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2029-06-30

F1 · derivative.exercise_date: Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the reporting person's first date of employment and 2.0833% of the shares vesting monthly thereafter.

Read SEC document
June 14, 2019 Filed Jun 17, 2019 23:21 UTC
Notman DonaldChief Financial Officer
PurchaseCommon Stock 2,500 $4.33 $10,825.00
Disclosure

SEC source: 0001104659-19-036009 · a4.xml · nonDerivative · entry 1

Notman Donald · CIK 0001718019 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,049

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.31 to $4.33, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

F2 · balance_after: Includes 4,249 shares acquired under the 2014 Ocular Therapeutix, Inc. Employee Stock Purchase Plan on December 31, 2018.

Read SEC document
June 14, 2019 Filed Jun 17, 2019 23:21 UTC PurchaseCommon Stock 4,500 $4.40 $19,800.00
Disclosure

SEC source: 0001104659-19-036008 · a4.xml · nonDerivative · entry 1

Williams Leslie J. · CIK 0001770465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,500

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.32 to $4.44, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
June 11, 2019 Filed Jun 13, 2019 17:18 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $3.90 $0.00
Disclosure

SEC source: 0001104659-19-035410 · a4.xml · derivative · entry 1

LINDSTROM RICHARD L MD · CIK 0001242177 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2029-06-10

F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date.

Read SEC document
June 11, 2019 Filed Jun 13, 2019 17:19 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $3.90 $0.00
Disclosure

SEC source: 0001104659-19-035412 · a4.xml · derivative · entry 1

PEACOCK BRUCE · CIK 0001228459 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2029-06-10

F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date.

Read SEC document
June 11, 2019 Filed Jun 13, 2019 17:20 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $3.90 $0.00
Disclosure

SEC source: 0001104659-19-035413 · a4.xml · derivative · entry 1

Warden Charles M · CIK 0001354802 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2029-06-10

F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date.

Read SEC document
June 11, 2019 Filed Jun 13, 2019 21:20 UTC GrantStock Option (Right to Buy) · Derivative 36,000 $0.00 Strike: $3.90 $0.00
Disclosure

SEC source: 0001104659-19-035414 · a4.xml · derivative · entry 1

Hong Seung Suh · CIK 0001774271 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,000

Underlying: Common Stock · 36,000 shares

Expires 2029-06-10

F1 · derivative.exercise_date: Vests over three years, vesting 1/3 on each yearly anniversary of the date of grant.

Read SEC document
June 11, 2019 Filed Jun 13, 2019 21:19 UTC GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $3.90 $0.00
Disclosure

SEC source: 0001104659-19-035411 · a4.xml · derivative · entry 1

Heier Jeffrey S. · CIK 0001653082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2029-06-10

F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date.

Read SEC document
June 07, 2019 Filed Jun 10, 2019 20:55 UTC
Sawhney AmarpreetDirector · Chairman of the Board
PurchaseCommon Stock 65,468 $3.02 $197,713.36
Disclosure

SEC source: 0001104659-19-034633 · a4.xml · nonDerivative · entry 2

Sawhney Amarpreet · CIK 0001614417 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,056,031

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.85 to $3.20, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
June 06, 2019 Filed Jun 10, 2019 20:53 UTC
Mattessich Antony C.Director · President & CEO
PurchaseCommon Stock 40,000 $2.81 $112,400.00
Disclosure

SEC source: 0001104659-19-034632 · a4.xml · nonDerivative · entry 1

Mattessich Antony C. · CIK 0001709900 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,900

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.79 to $2.82, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
June 06, 2019 Filed Jun 10, 2019 20:55 UTC
Sawhney AmarpreetDirector · Chairman of the Board
PurchaseCommon Stock 59,000 $2.80 $165,200.00
Disclosure

SEC source: 0001104659-19-034633 · a4.xml · nonDerivative · entry 1

Sawhney Amarpreet · CIK 0001614417 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 990,563

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.73 to $2.88, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
June 05, 2019 Filed Jun 6, 2019 22:09 UTC
Sawhney AmarpreetDirector · Chairman of the Board
PurchaseCommon Stock 32,852 $2.91 $95,599.32
Disclosure

SEC source: 0001104659-19-034353 · a4.xml · nonDerivative · entry 2

Sawhney Amarpreet · CIK 0001614417 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 931,563

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.87 to $2.97, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
June 04, 2019 Filed Jun 6, 2019 22:09 UTC
Sawhney AmarpreetDirector · Chairman of the Board
PurchaseCommon Stock 12,928 $2.92 $37,749.76
Disclosure

SEC source: 0001104659-19-034353 · a4.xml · nonDerivative · entry 1

Sawhney Amarpreet · CIK 0001614417 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 898,711

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.89 to $2.95, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
May 28, 2019 Filed May 30, 2019 16:10 UTC
Goldstein Michael H.Chief Medical Officer
PurchaseCommon Stock 12,000 $2.51 $30,120.00
Disclosure

SEC source: 0001104659-19-032741 · a4.xml · nonDerivative · entry 1

Goldstein Michael H. · CIK 0001691259 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,686

Read SEC document
March 20, 2019 Filed Mar 22, 2019 23:02 UTC GrantStock Option (Right to Buy) · Derivative 36,000 $0.00 Strike: $4.16 $0.00
Disclosure

SEC source: 0001104659-19-016898 · a4.xml · derivative · entry 1

Williams Leslie J. · CIK 0001770465 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,000

Underlying: Common Stock · 36,000 shares

Expires 2029-03-19

F1 · derivative.exercise_date: Vests over three years, vesting 1/3 on each yearly anniversary of the date of grant.

Read SEC document
March 15, 2019 Filed Mar 18, 2019 18:20 UTC
Goldstein Michael H.Chief Medical Officer
PurchaseCommon Stock 10,000 $4.15 $41,500.00
Disclosure

SEC source: 0001104659-19-015691 · a4.xml · nonDerivative · entry 1

Goldstein Michael H. · CIK 0001691259 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,686

F1 · balance_after: Includes 2,986 shares acquired under the 2014 Ocular Therapeutix, Inc. Employee Stock Purchase Plan on December 31, 2018.

Read SEC document
March 15, 2019 Filed Mar 18, 2019 22:20 UTC PurchaseCommon Stock 24,000 $4.15 $99,600.00
Disclosure

SEC source: 0001104659-19-015692 · a4.xml · nonDerivative · entry 1

Heier Jeffrey S. · CIK 0001653082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.15 to $4.16, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
March 13, 2019 Filed Mar 14, 2019 16:14 UTC PurchaseCommon Stock 56,441 $4.33 $244,389.53
Disclosure

SEC source: 0001104659-19-014844 · a4.xml · nonDerivative · entry 1

LINDSTROM RICHARD L MD · CIK 0001242177 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Read SEC document
January 02, 2019 Filed Jan 4, 2019 23:26 UTC
Mattessich Antony C.Director · President and CEO
GrantStock Option (Right to Buy) · Derivative 400,000 $0.00 Strike: $4.10 $0.00
Disclosure

SEC source: 0001104659-19-000889 · a4.xml · derivative · entry 1

Mattessich Antony C. · CIK 0001709900 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2029-01-01

F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 18:26 UTC
Goldstein Michael H.Chief Medical Officer
GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $4.10 $0.00
Disclosure

SEC source: 0001104659-19-000887 · a4.xml · derivative · entry 1

Goldstein Michael H. · CIK 0001691259 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2029-01-01

F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 18:29 UTC
Bollag Daniel MSr. VP Reg. Affairs & Quality
GrantStock Option (Right to Buy) · Derivative 180,000 $0.00 Strike: $4.10 $0.00
Disclosure

SEC source: 0001104659-19-000894 · a4.xml · derivative · entry 1

Bollag Daniel M · CIK 0001461612 · Sr. VP Reg. Affairs & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common Stock · 180,000 shares

Expires 2029-01-01

F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 23:28 UTC
Hanley Kevin F.Sr. VP Technical Operations
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $4.10 $0.00
Disclosure

SEC source: 0001104659-19-000892 · a4.xml · derivative · entry 1

Hanley Kevin F. · CIK 0001727629 · Sr. VP Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2029-01-01

F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 23:28 UTC GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $4.10 $0.00
Disclosure

SEC source: 0001104659-19-000891 · a4.xml · derivative · entry 1

Sawhney Amarpreet · CIK 0001614417 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2029-01-01

F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 23:27 UTC
Notman DonaldChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $4.10 $0.00
Disclosure

SEC source: 0001104659-19-000890 · a4.xml · derivative · entry 1

Notman Donald · CIK 0001718019 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2029-01-01

F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Read SEC document
December 14, 2018 Filed Dec 18, 2018 13:52 UTC
Hanley Kevin F.See Remarks
PurchaseCommon Stock 10,000 $5.50 $55,000.00
Disclosure

SEC source: 0001104659-18-073444 · a4.xml · nonDerivative · entry 1

Hanley Kevin F. · CIK 0001727629 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
December 10, 2018 Filed Dec 12, 2018 21:35 UTC
Hanley Kevin F.SEE REMARKS
PurchaseCommon Stock 10,000 $5.60 $56,000.00
Disclosure

SEC source: 0001104659-18-072563 · a4.xml · nonDerivative · entry 1

Hanley Kevin F. · CIK 0001727629 · SEE REMARKS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Read SEC document
December 06, 2018 Filed Dec 10, 2018 16:15 UTC
Bollag Daniel MSee Remarks
PurchaseCommon Stock 17,400 $5.76 $100,224.00
Disclosure

SEC source: 0001104659-18-072100 · a4.xml · nonDerivative · entry 1

Bollag Daniel M · CIK 0001461612 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,100

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.75 to $5.79, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
August 20, 2018 Filed Aug 21, 2018 20:30 UTC
Mattessich Antony C.Director · President & CEO
PurchaseCommon Stock 20,000 $5.95 $119,000.00
Disclosure

SEC source: 0001104659-18-053039 · a4.xml · nonDerivative · entry 1

Mattessich Antony C. · CIK 0001709900 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,900

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.93 to $5.97, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
August 14, 2018 Filed Aug 15, 2018 21:13 UTC
Notman DonaldChief Financial Officer
PurchaseCommon Stock 12,500 $6.29 $78,625.00
Disclosure

SEC source: 0001104659-18-052308 · a4.xml · nonDerivative · entry 1

Notman Donald · CIK 0001718019 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,300

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.